Related Experiment Video
Updated: Jul 2, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Increased intraepithelial T-cells in stable COPD
Magnus J Löfdahl1, Ester Roos-Engstrand, Jamshid Pourazar
1Department of Medicine, Division of Respiratory Medicine, Karolinska Institutet, Solna, Stockholm, Sweden. magnus.lofdahl@karolinska.se
Respiratory Medicine
|August 19, 2008
Summary
Intraepithelial T-cells, specifically CD4+ and CD8+ subtypes, are elevated in chronic obstructive pulmonary disease (COPD) patients. These findings suggest a significant role for these T-cells in the inflammatory processes associated with COPD.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Background:
- The airway epithelium acts as a primary defense against inhaled irritants.
- Chronic obstructive pulmonary disease (COPD) is a progressive lung disease strongly linked to smoking.
- Intraepithelial T-cells are a distinct T-cell subset with potential regulatory functions.
Purpose of the Study:
- To investigate the role of intraepithelial T-cells in chronic obstructive pulmonary disease (COPD).
- To determine if T-cell populations are altered in COPD patients and associated with inflammation.
Main Methods:
- Bronchoscopic endobronchial mucosal biopsies were obtained from 22 stable COPD patients, 14 smokers, and 15 non-smokers.
- Airway inflammation was assessed using the Bronchitis Index (BI).
- Immunohistochemistry was used to analyze inflammatory cells in biopsy specimens.
Main Results:
- COPD patients showed significantly higher numbers of intraepithelial CD4+ T-cells compared to smokers and non-smokers.
- Intraepithelial CD8+ T-cell counts were elevated in COPD patients relative to non-smokers.
- Both COPD patients and smokers exhibited increased Bronchitis Index scores compared to non-smokers.
Conclusions:
- Intraepithelial CD4+ and CD8+ T-cells appear to play a role in stable COPD.
- These T-cells may be important in the chronic inflammatory response of COPD or serve a regulatory function.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...